Read about atopic dermatitis and itch this month
It is a timely topic as most of the USA is dealing with very cold weather and dry conditions, and itching is a challenging clinical problem.
Help shape the future of ACAAI!
As part of ACAAI’s commitment to enhancing your membership experience, we invite you to share your perspective on the College’s resources and where we can bett…
Calendar of Events
These events are developed and implemented by local, regional, or state medical societies and are certified by ACAAI for CME credit:
Medicare payment policies expire again
A brief lapse in funding is unlikely to trigger a full government shutdown of the agencies funded by the minibus
Claim denials for CPT code 95165 are growing
These requirements can significantly impact allergy practices that rely on preparing customized, multi-dose vials in advance.
Member benefit: employment contract service
The College has partnered with Resolve, a national firm specializing in physician employment contracts, to offer a valuable member benefit. Resolve provides ph…
January-February AllergyWatch targets nanobody molecules for asthma and more
In the current issue, you’ll find information about the use of nanobody molecules for asthma treatment, plus additional articles.
Help us align the College’s priorities with your needs
The current strategic plan is in its third year, and the College is actively planning for the 2027-2029 phase to address major issues.
The Senate HELP Committee seeks answers on CPT codes and coverage policies
Sen. Cassidy’s Request for Information (RFI) asks for specific data on the AMA’s licensing and royalty fees.
Issue with federal BCBS coverage of Xolair for IgE-mediated food allergy
Reports from members indicate that the FEP is denying coverage for Xolair unless the patient demonstrates confirmed allergies to peanuts plus at least two othe…
… results.
